1. Home
  2. CCD vs VALN Comparison

CCD vs VALN Comparison

Compare CCD & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Dynamic Convertible & Income Fund

CCD

Calamos Dynamic Convertible & Income Fund

HOLD

Current Price

$24.87

Market Cap

662.0M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.94

Market Cap

653.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCD
VALN
Founded
2014
2012
Country
United States
France
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
662.0M
653.3M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CCD
VALN
Price
$24.87
$6.94
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
51.9K
86.1K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
10.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.99
$4.75
52 Week High
$26.99
$12.23

Technical Indicators

Market Signals
Indicator
CCD
VALN
Relative Strength Index (RSI) 39.36 59.03
Support Level $23.68 $5.10
Resistance Level $24.64 $7.31
Average True Range (ATR) 0.42 0.21
MACD -0.11 -0.02
Stochastic Oscillator 17.34 51.19

Price Performance

Historical Comparison
CCD
VALN

About CCD Calamos Dynamic Convertible & Income Fund

Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: